Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no study data, eligibility criteria, or page functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing v3.4.0 (a minor site update). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary option was added. The page metadata was updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', and it removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. The update does not affect the study details or other information shown on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedDifference1%

- Check85 days agoChange DetectedRevision: v3.3.2 was applied. No substantive changes to the study details or page purpose are evident.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.